<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01265303</url>
  </required_header>
  <id_info>
    <org_study_id>UDAPOIG.01.03.01-00-068/09-00D</org_study_id>
    <nct_id>NCT01265303</nct_id>
  </id_info>
  <brief_title>Telemetric Arrhythmia and Syncope Diagnosis - Evaluation of Arrhythmia Treatment Efficacy</brief_title>
  <acronym>TELEMARC 4</acronym>
  <official_title>OPTIMIZING DIAGNOSTICS AND THERAPY OF ARRHYTHMIA AND SYNCOPE EVENTS USING INTELLIGENT TELEMETRIC SOLUTIONS - Evaluation of Arrhythmia Treatment Efficacy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institute of Cardiology, Warsaw, Poland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institute of Cardiology, Warsaw, Poland</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess efficacy of prolonged Full Disclosure ECG monitoring
      and signal analysis using advanced GSM telemetric technology to prescribe the most
      appropriate treatment of arrhythmia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Non-invasive methods enabling long-term ECG monitoring in patients with paroxysmal symptoms,
      such as tachycardia or palpitations increase the probability of detecting infrequent but
      dangerous events with profound clinical significance. Patients with recommendation for the
      first catheter ablation of Paroxysmal Atrial Fibrillation in the reference center will be
      included in the study. Eligible patients will have 14-day telemetric ECG monitoring. Based on
      detected arrhythmia events, patient's medical history and available documentation the most
      appropriate treatment will be recommended. Patients will undergo invasive procedures of
      ablation or pacemaker implantation or can be treated pharmacologically. After the invasive
      treatment or initiation of pharmacotherapy the 14-day telemetric ECG monitoring will be
      repeated to assess efficacy of the treatment.

      Patients with no record of arrhythmia requiring treatment during the first 14 days ECG
      monitoring will terminate participation in the study. The referring physician will be
      informed. Further diagnosis or treatment should be performed at the referring physician's
      center according to the best clinical practice.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>February 2011</start_date>
  <completion_date type="Anticipated">March 2014</completion_date>
  <primary_completion_date type="Anticipated">March 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Occurence of atrial fibrillation</measure>
    <time_frame>14 days since the start of monitoring</time_frame>
    <description>Confirmation of indication for catheter ablation of atrial fibrillation by detection of incidence of AF event during 14 days ECG monitoring</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Therapy efficacy analysis</measure>
    <time_frame>14 days</time_frame>
    <description>The mean atrial fibrillation burden reduction</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Indication for treatment other than catheter ablation</measure>
    <time_frame>14 days</time_frame>
    <description>Confirmation of indication for treatment other than catheter ablation such as: pacemaker or pharmacotherapy by detetion of:
arrhythmia other than AF qualifying for treatment
Bradycardia &lt; 40 BPM
Pauses &gt; 2,5 s on sinus rhythm or &gt; 3,5 on AF</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation of patient self assessment based on the Quality of Life questionnaire and European Heart Rhythm Association (EHRA) scale with cardiac arrhythmia occurrence.</measure>
    <time_frame>14 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of stroke and bleeding risk factors incidence based on scores proposed in the European Society of Cardiology (ESC) guidelines: CHADS2VASC2 and HAS-BLED</measure>
    <time_frame>14 days</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">360</enrollment>
  <condition>Atrial Fibrillation</condition>
  <condition>Arrhythmias, Cardiac</condition>
  <arm_group>
    <arm_group_label>Catheter ablation</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Pacemaker implantation</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Pharmacotherapy</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Prolonged telemetric Full Disclosure ECG recording.</intervention_name>
    <description>Continuous Full Disclosure Telemetric ECG monitoring lasting 14 days</description>
    <arm_group_label>Catheter ablation</arm_group_label>
    <arm_group_label>Pacemaker implantation</arm_group_label>
    <arm_group_label>Pharmacotherapy</arm_group_label>
    <other_name>Medicalgorithmics, PocketECG</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age - between 18 and 80 years old

          -  Physician recommendation for ablation treatment of arrhythmia

          -  Patient informed consent

          -  Declarative and feasible compliance (patient understands basic instructions regarding
             device use)

        Exclusion Criteria:

          -  Inability to comply with the study protocol

          -  Lack of patient cooperation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lukasz J Szumowski, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Institute of Cardiology, Warsaw, Poland</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lukasz Szumowski, MD, PhD</last_name>
    <phone>+48501152728</phone>
    <email>lszumowski@ikard.pl</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Zbigniew Jedynak, MD, PhD</last_name>
    <phone>+48603786780</phone>
    <email>zjedynak@ikard.pl</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Universitair Ziekenhuis Brussel Centre for Heart- and Vascular diseases</name>
      <address>
        <city>Brussel</city>
        <zip>1090</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pedro Brugada, MD PhD</last_name>
      <phone>+32 2 477 60 09</phone>
      <email>chvz@uzbrussel.be</email>
    </contact>
    <contact_backup>
      <last_name>Carlo de Asmundis, MD</last_name>
      <phone>+32 2 477 60 09</phone>
      <email>chvz@uzbrussel.be</email>
    </contact_backup>
    <investigator>
      <last_name>Carlo de Asmundis, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinika Kardiologii CMKP</name>
      <address>
        <city>Warsaw</city>
        <zip>04-073</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Piotr Ku≈Çakowski, MD PhD</last_name>
      <phone>+48 22 8101738</phone>
      <email>kulak@kkcmkp.pl</email>
    </contact>
    <investigator>
      <last_name>Jakub Baran, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sebastian Stec, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Institute of Cardiology</name>
      <address>
        <city>Warsaw</city>
        <zip>04-628</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lukasz Szumowski, Prof,</last_name>
      <phone>+48 22 501152728</phone>
      <email>lszumowski@ikard.pl</email>
    </contact>
    <investigator>
      <last_name>Lukasz Szumowski, Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Zbigniew Jedynak, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>Poland</country>
  </location_countries>
  <verification_date>May 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 22, 2010</study_first_submitted>
  <study_first_submitted_qc>December 22, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 23, 2010</study_first_posted>
  <last_update_submitted>May 6, 2013</last_update_submitted>
  <last_update_submitted_qc>May 6, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 7, 2013</last_update_posted>
  <responsible_party>
    <name_title>Prof Lukasz Szumowski</name_title>
    <organization>Institute of Cardiology, Warsaw Poland</organization>
  </responsible_party>
  <keyword>ablation, cardiac arrhythmia, atrial fibrillation, telemonitoring, telemetry</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
    <mesh_term>Syncope</mesh_term>
    <mesh_term>Arrhythmias, Cardiac</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

